Friday, August 29, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Arrow Financial Corporation Experiences Decline in Q4 GAAP EPS and Cash Reserves

Elaine Mendonca by Elaine Mendonca
February 1, 2024
in Breaking News
0
Finance_Assets
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As of February 1, 2024, Arrow Financial Corporation delivered a notable decline in its Q4 GAAP EPS, plummeting from $0.71 to $0.46 compared to the previous year. The company’s financial statement revealed that their total cash and cash equivalents stood at $142.5 million as of December 31, 2022. This figure showcases a substantial decrease in comparison to the previous quarter’s total of $334 million in cash and cash equivalents. These numbers hold immense significance as they serve as crucial indicators of Arrow Financial Corporation’s liquidity and its capacity to fulfill short-term obligations.

AROW Stock Shows Mixed Performance on February 1, 2024: Investors Monitor for Potential Downward Trend

On February 1, 2024, AROW stock displayed a mixed performance. It traded in the middle of its 52-week range and above its 200-day simple moving average. The price of AROW shares experienced a decline of $1.24 since the market last closed, representing a drop of 4.69% in value. AROW closed at $25.19. In after-hours trading, AROW stock remained unchanged. Investors should monitor the stock’s performance in the coming days to assess whether the decline is temporary or a signal of a more significant downward trend. Further research and analysis, including examining the company’s financials and news developments, can provide a more comprehensive understanding of AROW’s stock performance.

AROW Stock Performance: Positive Revenue Growth and Improving Net Income and EPS

AROW Stock Performance on February 1, 2024

On February 1, 2024, AROW stock demonstrated positive performance, driven by strong financial results for the company. According to data sourced from CNN Money, AROW’s total revenue for the past year stood at $160.55 million, marking an increase of 8.54% compared to the previous year. Additionally, the total revenue for the third quarter of the same year amounted to $50.17 million, indicating a growth of 6.92% since the previous quarter.

Despite the positive revenue growth, AROW’s net income remained relatively flat compared to the previous year. The net income for the past year was reported at $48.80 million, showing no significant change. However, there was a notable improvement in net income for the third quarter of 2024, which increased by 28.05% compared to the previous quarter, reaching $7.74 million.

Earnings per share (EPS) is an important metric for investors, and AROW’s performance in this area also exhibited positive trends. The EPS for the past year remained stable at $2.86, showing no change compared to the previous year. However, the EPS for the third quarter of 2024 increased by 28.02% compared to the previous quarter, reaching $0.45.

The overall stock performance on February 1, 2024, was influenced by the company’s revenue growth and the significant improvement in net income and EPS during the third quarter. Despite the flat net income and EPS for the past year, the positive trends observed in the most recent quarter indicate the potential for future growth and profitability.

Investors may view AROW’s consistent revenue growth as a positive sign, as it demonstrates the company’s ability to generate consistent sales. Additionally, the improvement in net income and EPS during the third quarter suggests that AROW has been able to effectively manage its expenses and enhance its profitability.

It is important to note that stock performance is subject to various factors, including market conditions, investor sentiment, and industry trends. While the financial performance of AROW on February 1, 2024, indicates positive growth, it is recommended that investors conduct thorough research and analysis before making any investment decisions.

Tags: AROW
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Capitalization

StoneCo NASDAQ STNE Downgraded to Neutral by UBS Analyst with Revised Price Target

Food Retailers Stock Market Today

Tractor Supplys Quarterly Earnings Report and Challenges

Graviton Bioscience Secures Significant Investment from Sanofi for ROCK2 Inhibitor Treatments

Recommended

Kid eating pbj

Shell Withdraws from Petrochemicals Plant Negotiations in Basra

2 years ago
Aerospace and Defense Markets and money

Title General Electric CEO Expresses Confidence in CFMs Engine Manufacturing Capabilities

1 year ago
Real Estate Investment Markets and money

Blackwells Capital Urges Shareholders to Vote for Their Nominees at Disneys Annual Meeting 2024

2 years ago
Workplace design

The Future of Workplace Design: Integrating Sustainability and High-Performance Spaces in Urban Environments

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Commodities
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL Adobe ADSK Alibaba AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DELL DIS DWAC Eli Lilly GM IBM INTC Intel LLY META Micron MP Materials MSFT NFLX NIO NVO Opendoor Oracle Palantir PARA PLTR Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Precigen Stock Surges on Breakthrough FDA Approval for Novel Therapy

Cross Country Healthcare Faces Dual Setback from Earnings Miss and Merger Delay

CVRx Shares Present Mixed Picture Following Q2 Earnings Release

Rheinmetall Stock: Strategic Expansion Amid Market Correction

Idorsia Secures Financial Lifeline Amid Cautious Market Response

SAP’s Strategic Acquisition: A Bold Move in HR Technology

Trending

Marvell Technology Stock
Stocks

When Record Results Aren’t Enough: Marvell Technology’s AI Hype Fades

by Dieter Jaworski
August 29, 2025
0

Marvell Technology Inc. delivered what should have been a celebratory quarterly earnings report, yet investors responded with...

Terreno Realty Stock

The Unseen Powerhouse in Industrial Real Estate

August 29, 2025
Capital City Bank Stock

Capital City Bank Shares Approach Annual Peak Amid Sustained Rally

August 29, 2025
Precigen Stock

Precigen Stock Surges on Breakthrough FDA Approval for Novel Therapy

August 29, 2025
Cross Country Healthcare Stock

Cross Country Healthcare Faces Dual Setback from Earnings Miss and Merger Delay

August 29, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • When Record Results Aren’t Enough: Marvell Technology’s AI Hype Fades August 29, 2025
  • The Unseen Powerhouse in Industrial Real Estate August 29, 2025
  • Capital City Bank Shares Approach Annual Peak Amid Sustained Rally August 29, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Commodities
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com